Restoring a gut Bifidobacterium community in early infancy
- PMID: 41380667
- DOI: 10.1016/j.chom.2025.10.017
Restoring a gut Bifidobacterium community in early infancy
Abstract
An early-life microbiota with increased Bifidobacterium and human milk oligosaccharide (HMO) utilization genes has been linked to decreased risk of childhood allergic disease. As infant microbiomes increasingly have reduced Bifidobacterium, we examine early-life dysbiosis and interventions that potentially prevent or reverse this dysbiotic state, thus mitigating noncommunicable diseases.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests R.A.I. is a scientific advisor to and holds stock options in Persephone Biosciences, Inc. and holds stock options in Kenvue. J.B.J., P.J.T., S.V.D., and S.J.C are employed by Persephone Biosciences, Inc. and hold stock and/or stock options. Persephone Biosciences, Inc has filed patents related to the My Baby Biome study with all these Persephone Biosciences, Inc. co-authors named inventors on the patents. W.M.d.V. is co-founder and holds stock in Alba Health and The Akkermansia Company.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
